News
Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease
Konikoff MR, Denson LA, Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, concluded in their review in Inflamm Bowel Dis. 2006 Jun;12(6):524-34, that fecal calprotectin correlates well with histological inflammation as detected by colonoscopy with biopsies and has been shown successfully to predict relapses and detect pouchitis in patients with IBD
Fecal calprotectin has been shown to consistently differentiate IBD from irritable bowel syndrome because it has excellent negative predictive value in ruling out IBD in undiagnosed, symptomatic patients. Fecal calprotectin also may be useful in determining whether clinical symptoms in patients with known IBD are caused by disease flares or noninflammatory complications/underlying irritable bowel syndrome and in providing objective evidence of response to treatment. PMID: 16775498
Next page: Newsletters Previous page: News
